ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes

June 11, 1993

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980